Full Report

Format

Full Report
Summary (Text)
Summary (XML)

Send to:

Choose Destination

File
Clipboard
Collections

Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder

MedGen UID:: 276575
•Concept ID:: C1518374
•: Disease or Syndrome

Synonyms:

Non-Malignant Hematologic and Lymphocytic Disorder; Non-Neoplastic Hematologic and Lymphocytic Disorder; Non-Neoplastic Hematologic and Lymphoid Cell Disorder

Definition

A non-neoplastic disorder that arises from hematopoietic and lymphoid cells. It is characterized by the absence of a clonal cellular component. It rarely progresses to a malignant neoplasm. [from NCI]

Term Hierarchy

GTR
MeSH

CClinical test, RResearch test, OOMIM, GGeneReviews, VClinVar

CROGVNon-Neoplastic Hematopoietic and Lymphoid Cell Disorder

Pathological Conditions, Signs and Symptoms
- Pathological process
  - Disease
    - Disorder by Site
      - Hematopoietic and Lymphatic System Disorder
        Hematologic disorder
        Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder
        Abnormality of the coagulation cascade
        Abnormal bleeding
        Abnormal onset of bleeding
        Abnormal umbilical stump bleeding
        Bleeding requiring red cell transfusion
        Bleeding with minor or no trauma
        Cephalohematoma
        Epistaxis
        Excessive bleeding after a venipuncture
        Excessive bleeding from superficial cuts
        Gingival bleeding
        Menorrhagia
        Persistent bleeding after trauma
        Prolonged bleeding following procedure
        Prolonged bleeding time
        Abnormality of prothrombin
        Abnormal prothrombin time
        Reduced prothrombin antigen
        Reduced prothrombin consumption
        Abnormality of the common coagulation pathway
        Abnormal coagulation factor V activity
        Abnormality of circulating fibrinogen
        Decreased level of heparin co-factor II
        Decreased level of histidine-rich glycoprotein
        Decreased level of thrombomodulin
        Decreased level of tissue plasminogen activator
        Increased plasma vitamin K epoxide after vitamin K supplementation
        Prolonged Russell viper venom time
        Reduced alpha-2-antiplasmin activity
        Reduced antithrombin antigen
        Reduced factor X activity
        Reduced factor XIII activity
        Abnormality of the extrinsic pathway
        Reduced factor VII activity
        Abnormality of the intrinsic pathway
        Abnormal factor IX activity
        Abnormal factor VIII activity
        Factor XII deficiency disease
        Hereditary antithrombin deficiency
        High molecular weight kininogen deficiency
        Reduced factor XI activity
        Abnormality of the protein C anticoagulant pathway
        Reduced protein C activity
        Reduced protein S activity
        Resistance to activated protein C
        Abnormality of von Willebrand factor
        Abnormal von Willebrand factor multimer distribution
        Enhanced ristocetin cofactor assay activity
        Impaired binding of factor VIII to VWF
        Impaired ristocetin cofactor assay activity
        Impaired ristocetin-induced platelet aggregation
        Impaired von Willebrand factor collagen binding activity
        Increased ratio of VWF propeptide to VWF antigen
        Reduced quantity of Von Willebrand factor
        Reduced von Willebrand factor activity
        Blood coagulation disorder due to liver disease
        Coagulation factor deficiency syndrome
        Acquired coagulation factor deficiency
        Factor V deficiency
        Factor VII deficiency
        Factor X deficiency
        Factor XIII deficiency
        Fibrinogen deficiency
        Hemophilia
        Hereditary coagulation factor deficiency
        Prothrombin deficiency
        Tissue Factor Deficiency
        Coagulation protein disease
        Afibrinogenemia
        Congenital factor V deficiency
        Hereditary factor IX deficiency disease
        Hereditary factor VIII deficiency disease
        Hereditary factor XI deficiency disease
        Hereditary factor XIII deficiency disease
        von Willebrand disorder
        Congenital Bleeding Disorder
        Congenital plasminogen activator inhibitor type 1 deficiency
        COVID-19-Associated Coagulation Disorder
        COVID-19-Associated Thromboembolism
        Disseminated intravascular coagulation
        Acute disseminated intravascular coagulation
        Chronic disseminated intravascular coagulation
        Disseminated intravascular coagulation in newborn
        Dysfibrinogenemia
        Ecchymosis
        Battle sign
        Conjunctival Ecchymosis
        Ecchymosis of gingivae
        Essential thrombocythemia
        Thrombocythemia 1
        Thrombocythemia 2
        Thrombocythemia 3
        Fibrinolysis Shutdown
        Hemolytic-uremic syndrome
        Atypical hemolytic-uremic syndrome
        Atypical hemolytic-uremic syndrome with DGKE deficiency
        Cobalamin C disease
        D-plus hemolytic uremic syndrome (D+HUS)
        Diarrhea-associated hemolytic uremic syndrome
        Diarrhea-negative hemolytic uremic syndrome
        Infection-related hemolytic uremic syndrome
        Hyperfibrinogenemia
        Immune-Mediated Coagulopathy
        Inherited blood coagulation disorder
        Bernard Soulier syndrome
        Glanzmann thrombasthenia
        Gray platelet syndrome
        Hermansky-Pudlak syndrome
        Upshaw-Schulman syndrome
        Wiskott-Aldrich syndrome
        Plasma Kallikrein Deficiency
        Platelet-type bleeding disorder 17
        Protein S deficiency disease
        Purpura
        Hyperglobulinemic purpura
        Immunoglobulin A vasculitis
        Macular purpura
        Palpable purpura
        Purpura fulminans
        Thrombocytopenic purpura
        Vascular purpura
        Waterhouse-Friderichsen Syndrome
        Storage pool disease of platelets
        Thromboinflammation
        Thrombophilia
        Hereditary thrombophilia
        Thrombotic thrombocytopenic purpura
        Thrombotic microangiopathy
        Systemic lupus erythematosus
        Transplant-Associated Thrombotic Microangiopathy
        Tissue Kallikrein Deficiency
        Vitamin K deficiency
        Vitamin K Deficiency Bleeding
        Amegakaryocytosis
        Congenital Amegakaryocytosis
        Non-Congenital Amegakaryocytosis
        Anemia
        Anemia due to chronic disorder
        Anemia due to Decreased Production
        Anemia due to Disorder of Glutathione Metabolism
        Anemia due to disorders of nucleotide metabolism
        Uridine monophosphate hydrolase deficiency
        Anemia due to enzyme disorder
        Anemia due to erythrocyte enzyme disorder
        Anemia due to Increased Destruction
        Anemia due to reduced life span of red cells
        Hemolytic anemia
        Increased red cell sickling tendency
        Anemia of inadequate production
        Hypochromic anemia
        Hypoplastic anemia
        Macrocytic anemia
        Microcytic anemia
        Normochromic anemia
        Normocytic anemia
        Sideroblastic anemia
        Anemia of prematurity
        Aplastic anemia
        Aplastic anemia due to drugs
        Aplastic anemia due to infection
        Aplastic anemia due to radiation
        Hypoplastic anemia - familial
        Idiopathic aplastic anemia
        Non-Severe Aplastic Anemia
        Recurrent Aplastic Anemia
        Severe Aplastic Anemia
        Very Severe Aplastic Anemia
        Congenital anemia
        Congenital dyserythropoietic anemia
        Familial hemolytic anemia
        Hereditary sideroblastic anemia
        Hypochromia
        Mild Anemia
        Myelophthisic anemia
        Neonatal anemia
        Fetal-maternal hemorrhage
        Twin-to-twin transfusion
        Pure red-cell aplasia
        Acquired red cell aplasia
        Diamond-Blackfan anemia
        Radiation Anemia
        Refractory anemia
        Myelodysplastic syndrome with excess blasts
        Steroid-responsive anemia
        Transient erythroblastopenia
        Treatment-Induced Anemia
        Benign Lymphoproliferative Disorder
        Chronic lymphoproliferative disorder of NK-cells
        Follicular Bronchitis/Bronchiolitis
        Infectious mononucleosis
        Lymphadenitis
        Acute lymphadenitis
        Axillary lymphadenitis
        Cat scratch disease
        cervical lymphadenitis
        Chronic lymphadenitis
        Kikuchi-Fujimoto disease
        Kimura disease
        Mesenteric lymphadenitis
        Postauricular lymphadenitis
        Submandibular adenitis
        Suppurative lymphadenitis
        Lymphocytoma cutis
        Congenital hematological disorder
        Beta-thalassemia-X-linked thrombocytopenia syndrome
        Congenital Abnormalities of Erythrocyte Differentiation or Function
        Congenital neutropenia
        Severe congenital neutropenia
        Congenital Platelets Abnormality
        Genetic anomaly of leukocyte
        Hemoglobinopathy
        Hb SS disease
        Hemoglobin C disease
        Hemoglobin D disease
        Hemoglobin E disease
        Hemoglobin Trait
        Sickle cell-beta-thalassemia
        Sickle cell-hemoglobin C disease
        Sickle cell-hemoglobin D disease
        Sickle cell-hemoglobin E disease syndrome
        Sickle cell-Hemoglobin O Arab disease
        Sickle cell-thalassemia disease
        Thalassemia
        Vaso-Occlusive Crisis
        Hereditary methemoglobinemia
        Deficiency of cytochrome-b5 reductase
        Methemoglobin reductase deficiency
        Methemoglobinemia type 4
        Thrombocytopenia 1
        Thrombocytopenia, X-linked, with or without dyserythropoietic anemia
        Cyclical neutropenia
        Cyclic neutropenia in myeloid maturation arrest in bone marrow
        Evans syndrome
        Functional disorder of polymorphonuclear neutrophil
        Chronic granulomatous disease
        Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
        Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1
        Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2
        Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
        Granulomatous disease, chronic, X-linked
        Chédiak-Higashi syndrome
        Aleutian disease
        Leukocyte adhesion deficiency
        Leukocyte adhesion deficiency 1
        Leukocyte adhesion deficiency 3
        Leukocyte adhesion deficiency type II
        Pelger-Huët anomaly
        Inherited bleeding disorder, platelet-type
        Qualitative platelet disorder
        Thrombocytopenia
        11q partial monosomy syndrome
        Amegakaryocytic thrombocytopenia
        Congenital thrombocytopenia
        Heparin-induced thrombocytopenia
        Intermittent thrombocytopenia
        Kasabach-Merritt syndrome
        Neonatal alloimmune thrombocytopenia
        Post-transfusion thrombocytopenia
        Thrombocytosis
        Familial thrombocytosis
        Methemoglobinemia
        Acquired methemoglobinemia
        Drug-induced methemoglobinemia
        Toxic methemoglobinemia with cyanosis
        Neonatal Leukopenia
        Paroxysmal nocturnal hemoglobinuria
        Sinus histiocytosis with massive lymphadenopathy
        Bone Rosai-Dorfman-Destombes Disease
        Cutaneous Rosai-Dorfman-Destombes Disease
        Massive Sinusoidal Histiocytic Infiltrate
        Thyroid Gland Rosai-Dorfman-Destombes Disease
        Spherocytosis
        Hereditary spherocytosis
        Hereditary spherocytosis type 1
        Hereditary spherocytosis type 2
        Hereditary spherocytosis type 3
        Hereditary spherocytosis type 4
        Hereditary spherocytosis type 5
        Microspherocytosis

Professional guidelines

PubMed

Pleural effusion aetiology, presentation, treatment and outcome in haematological diseases: a review.

Fantin A, Castaldo N, Vailati P, Morana G, Orso D, Vetrugno L, Patruno V
Acta Biomed 2021 Nov 3;92(5):e2021268. doi: 10.23750/abm.v92i5.11794. PMID: 34738567 Free PMC Article

Drug-Induced Neutropenia During Treatment of Non-Neoplastic Dermatologic Diseases: A Review.

Hsieh CY, Tsai TF
Clin Drug Investig 2020 Oct;40(10):915-926. doi: 10.1007/s40261-020-00956-w. PMID: 32691244

The use of chemotherapeutic agents in the treatment of non-neoplastic diseases.

Barland P
J Chronic Dis 1971 May;23(12):829-42. doi: 10.1016/0021-9681(71)90013-0. PMID: 4934683

See all (10)

Recent clinical studies

Etiology

CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial.

Sallman DA, Kerre T, Havelange V, Poiré X, Lewalle P, Wang ES, Brayer JB, Davila ML, Moors I, Machiels JP, Awada A, Alcantar-Orozco EM, Borissova R, Braun N, Dheur MS, Gilham DE, Lonez C, Lehmann FF, Flament A
Lancet Haematol 2023 Mar;10(3):e191-e202. Epub 2023 Feb 7 doi: 10.1016/S2352-3026(22)00378-7. PMID: 36764323

The Importance of Nephropathology in Kidney Cancer.

Henriksen KJ, Chang A
Semin Nephrol 2020 Jan;40(1):69-75. doi: 10.1016/j.semnephrol.2019.12.008. PMID: 32130968

Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.

Hue SS, Oon ML, Wang S, Tan SY, Ng SB
Pathology 2020 Jan;52(1):111-127. Epub 2019 Nov 22 doi: 10.1016/j.pathol.2019.09.011. PMID: 31767131

Histiocytosis - cutaneous manifestations of hematopoietic neoplasm and non-neoplastic histiocytic proliferations.

Luder CM, Nordmann TM, Ramelyte E, Mühleisen B, Kerl K, Guenova E, Dummer R
J Eur Acad Dermatol Venereol 2018 Jun;32(6):926-934. Epub 2018 Jan 31 doi: 10.1111/jdv.14794. PMID: 29341328

Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis.

Rossetto V, Spiezia L, Senzolo M, Rodriguez K, Gavasso S, Woodhams B, Simioni P
Int J Lab Hematol 2013 Feb;35(1):101-5. Epub 2012 Sep 10 doi: 10.1111/ijlh.12003. PMID: 22958499

See all (111)

Diagnosis

Morphologic Characteristics of Myelodysplastic Syndromes.

Yuen LD, Hasserjian RP
Clin Lab Med 2023 Dec;43(4):577-596. Epub 2023 Aug 9 doi: 10.1016/j.cll.2023.06.003. PMID: 37865504

Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.

Hue SS, Oon ML, Wang S, Tan SY, Ng SB
Pathology 2020 Jan;52(1):111-127. Epub 2019 Nov 22 doi: 10.1016/j.pathol.2019.09.011. PMID: 31767131

How I investigate Eosinophilia.

Larsen RL, Savage NM
Int J Lab Hematol 2019 Apr;41(2):153-161. Epub 2018 Nov 30 doi: 10.1111/ijlh.12955. PMID: 30499630

How I investigate monocytosis.

Lynch DT, Hall J, Foucar K
Int J Lab Hematol 2018 Apr;40(2):107-114. Epub 2018 Jan 18 doi: 10.1111/ijlh.12776. PMID: 29345409

"Periportal neoplasms"--a CT perspective: review article.

Singh A, Chandrashekhara SH, Handa N, Baliyan V, Kumar P
Br J Radiol 2016;89(1060):20150756. Epub 2016 Jan 22 doi: 10.1259/bjr.20150756. PMID: 26800313 Free PMC Article

See all (174)

Therapy

Health status of petrochemical workers: a narrative review.

Fassio F, Bussa M, Oddone E, Ferraro OE, Puci MV, Morandi A, Castaldo F, Broi M, Uberti F, Villani S, Montomoli C, Monti MC
G Ital Med Lav Ergon 2022 Mar;44(1):51-58. PMID: 36346299

Drug-Induced Neutropenia During Treatment of Non-Neoplastic Dermatologic Diseases: A Review.

Hsieh CY, Tsai TF
Clin Drug Investig 2020 Oct;40(10):915-926. doi: 10.1007/s40261-020-00956-w. PMID: 32691244

SMYD2 is highly expressed in pediatric acute lymphoblastic leukemia and constitutes a bad prognostic factor.

Sakamoto LH, Andrade RV, Felipe MS, Motoyama AB, Pittella Silva F
Leuk Res 2014 Apr;38(4):496-502. Epub 2014 Feb 5 doi: 10.1016/j.leukres.2014.01.013. PMID: 24631370

Acute leukaemia following prolonged chlorambucil treatment for non-neoplastic disease - a study of two cases and literature review.

Aymard JP, Lederlin P, Witz F, Rumilly F, Eisemann JC, Buisine J, Gregoire MJ, Guerci O, Streiff F
Acta Clin Belg 1983;38(4):228-35. doi: 10.1080/22953337.1983.11718936. PMID: 6415985

See all (65)

Prognosis

Significance of SF3B1 Mutations in Myeloid Neoplasms.

Gajzer DC, Yeung CCS
Clin Lab Med 2023 Dec;43(4):597-606. Epub 2023 Sep 4 doi: 10.1016/j.cll.2023.07.005. PMID: 37865505

Morphologic Characteristics of Myelodysplastic Syndromes.

Yuen LD, Hasserjian RP
Clin Lab Med 2023 Dec;43(4):577-596. Epub 2023 Aug 9 doi: 10.1016/j.cll.2023.06.003. PMID: 37865504

Distinguishing autoimmune myelofibrosis from primary myelofibrosis.

Marcellino B, El Jamal SM, Mascarenhas JO
Clin Adv Hematol Oncol 2018 Sep;16(9):619-626. PMID: 30256778

Hypereosinophilia in childhood acute lymphoblastic leukaemia at diagnosis: report of 2 cases and review of the literature.

Parasole R, Petruzziello F, De Matteo A, Maisto G, Castelli L, Errico ME, Menna G, Poggi V
Ital J Pediatr 2014 Apr 10;40:36. doi: 10.1186/1824-7288-40-36. PMID: 24717004 Free PMC Article

Gastric mucosal polyps in pernicious anaemia.

Elsborg L, Andersen D, Myhere-Jensen O, Bastrup-Madsen P
Scand J Gastroenterol 1977;12(1):49-52. PMID: 65002

See all (98)

Clinical prediction guides

Significance of SF3B1 Mutations in Myeloid Neoplasms.

Gajzer DC, Yeung CCS
Clin Lab Med 2023 Dec;43(4):597-606. Epub 2023 Sep 4 doi: 10.1016/j.cll.2023.07.005. PMID: 37865505

Sensitivity of canine hematological cancers to BH3 mimetics.

Jegatheeson S, Cannon C, Mansfield C, Devlin J, Roberts A
J Vet Intern Med 2023 Jan;37(1):236-246. Epub 2022 Nov 25 doi: 10.1111/jvim.16587. PMID: 36433867 Free PMC Article

Elevated levels of p53 protein in the neutrophils and monocytes of a patient with chronic idiopathic thrombocytopenic purpura or possible early myelodysplasia?

Guinn BA, al-Sabah AI, Hewlett C, Padua RA
Leuk Res 1995 Oct;19(10):727-31. doi: 10.1016/0145-2126(95)00047-r. PMID: 7500649

Gastric mucosal polyps in pernicious anaemia.

Elsborg L, Andersen D, Myhere-Jensen O, Bastrup-Madsen P
Scand J Gastroenterol 1977;12(1):49-52. PMID: 65002

Constipated plasma cells associated with monomeric macroglobulinemia.

Lough J, Shuster J
Hum Pathol 1975 Mar;6(2):251-5. doi: 10.1016/s0046-8177(75)80178-x. PMID: 807515

See all (88)

Recent systematic reviews

Pleural effusion aetiology, presentation, treatment and outcome in haematological diseases: a review.

Fantin A, Castaldo N, Vailati P, Morana G, Orso D, Vetrugno L, Patruno V
Acta Biomed 2021 Nov 3;92(5):e2021268. doi: 10.23750/abm.v92i5.11794. PMID: 34738567 Free PMC Article

See all (1)

MedGen

National Center for Biotechnology Information